Brydge Capital announced the successful closing of a $6.5 million first round of funding for Harper Care to build the company’s ability to close the global gap in unmet mental health care.
Harper is a research-driven health technology company that provides highly personalized mental health patient support through a technology-based precision medicine framework. Brydge, a group of investors whose goal is to make healthcare innovation accessible at scale, led the round.
With more than a billion people worldwide struggling with their mental health, according to the World Health Organization, Harper’s clinical setting offers an effective and scalable response that can prevent the development of mental illness and provides ongoing care for those already affected.
Dr. Ved Sharma, Harper’s Chief Medical Officer, said: “We are thrilled with what this investment means for realizing our vision for Harper, which is to reach a much wider audience with our precision medicine approach. for preventive mental health care. Due to the widespread negative impacts of high stress on patients with physical illnesses, such as gastrointestinal and cardiometabolic disorders, or those facing the challenges of infertility, there is an urgent need for widely available tools for preventive approaches to mental health. Harper can implement the latest developments in medical technology to provide personalized support to make this possible at scale.
Nick Hocart, Partner at Brydge Capital, said: ” We have tracked the trend of increased investment in solutions targeting mental health and noted that they focus on supporting people generally when they are at their lowest point of health. We believe Harper has the team best positioned to fill the gap in the market where the focus is on prevention. The team has a unique mix of scientists, clinicians and technologists to deliver their solution. We are thrilled to support Harper as they transform the way mental health care is delivered.
Traditional mental health solutions, such as conventional therapy, are pathologizing and usually require diagnosis of illness. They are also expensive and difficult to access, generally limiting their use to responding to a crisis. Newer digital offerings provide catch-all resources, but without specialist support or human interaction.
Harper aims to make mental health care more objective, affordable and preventative through molecular biology and technology for earlier and more accurate detection. The clinical framework draws on molecular, bionumerical and psychological indicators of well-being for analysis by the team of clinicians, scientists and technologists. They continuously study the correlates and comorbid factors of mental health conditions, as well as the preconditions in populations, to provide optimal solutions at critical points in the patient journey.
Harper’s computer algorithm provides each patient with personalized, evidence-based interventions that progressively change behavior and improve outcomes. These are aligned with ongoing personal coaching, providing the support and accountability needed to maximize effectiveness.